Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

476
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
476
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.0K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Adaptive Induction of Nonshivering Thermogenesis in Muscle Rather Than Brown Fat Could Counteract Obesity.

Physiological research·2024
Same author

Expanding ecological assessment by integrating microorganisms into routine freshwater biomonitoring.

Water research·2021
Same author

Maternal diet, rather than obesity itself, has a main influence on milk triacylglycerol profile in dietary obese rats.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2019
Same author

Litter traits and rainfall reduction alter microbial litter decomposers: the evidence from three Mediterranean forests.

FEMS microbiology ecology·2019
Same author

Succession of Microbial Decomposers Is Determined by Litter Type, but Site Conditions Drive Decomposition Rates.

Applied and environmental microbiology·2019

Related Experiment Video

Updated: Dec 28, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.9K

Neurotoxicity and Immunotherapy.

J Kopecký

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |February 21, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Immunotherapy for solid tumors can cause immune-related adverse events, including rare but serious neurotoxicity. Increased physician and patient awareness and proper management are crucial for preventing severe complications.

    Keywords:
    imunotherapyipilimumabneurotoxicitynivolumab

    More Related Videos

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
    09:24

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

    Published on: April 15, 2014

    18.0K
    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    1.7K

    Related Experiment Videos

    Last Updated: Dec 28, 2025

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    21.9K
    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
    09:24

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

    Published on: April 15, 2014

    18.0K
    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    1.7K

    Area of Science:

    • Oncology
    • Immunology
    • Neurology

    Background:

    • Immunotherapy, particularly with checkpoint inhibitors, has advanced solid carcinoma treatment.
    • Immune-related adverse events (irAEs) are common, mimicking autoimmune diseases.
    • While often low-grade, less frequent toxicities like neurotoxicity can occur and may be fatal.

    Purpose of the Study:

    • To enhance physician and patient understanding of potential immunotherapy complications.
    • To emphasize the importance of proper management strategies for irAEs.
    • To promote proactive patient engagement in preventing adverse events.

    Main Methods:

    • This study focuses on the clinical presentation and management of immune-related adverse events in cancer immunotherapy.
    • Literature review and case study analysis on neurotoxicity as an irAE.
    • Analysis of current therapeutic interventions, including corticoid immunosuppression.

    Main Results:

    • Neurotoxicity is an infrequent but potentially severe immune-related adverse event associated with cancer immunotherapy.
    • Wider use of immunotherapeutics increases the likelihood of encountering rare irAEs, even outside specialized centers.
    • Delayed intervention or inadequate management of irAEs, including neurotoxicity, can lead to fatal outcomes.

    Conclusions:

    • Increased awareness and education regarding irAEs are vital for healthcare providers and patients undergoing immunotherapy.
    • Prompt and appropriate management, including timely immunosuppressive therapy, is critical for mitigating severe outcomes.
    • Proactive patient involvement and adherence to management protocols can improve safety and efficacy of cancer immunotherapy.